Your browser doesn't support javascript.
loading
A Systematic Evaluation of Cost-Saving Dosing Regimens for Therapeutic Antibodies and Antibody-Drug Conjugates for the Treatment of Lung Cancer.
Ter Heine, Rob; van den Heuvel, Michel M; Piet, Berber; Deenen, Maarten J; van der Wekken, Anthonie J; Hendriks, Lizza E L; Croes, Sander; van Geel, Robin M J M; Jansman, Frank G A; Boshuizen, Rogier C; Franssen, Eric J F; Smit, Arthur A J; Dumoulin, Daphne W; Oude Munnink, Thijs H; Smit, Egbert F; Derijks, Hieronymus J; van der Leest, Cor H; Hendrikx, Jeroen J M A; Moes, Dirk J A R; de Rouw, Nikki.
Afiliação
  • Ter Heine R; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands. r.terheine@radboudumc.nl.
  • van den Heuvel MM; Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Piet B; Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.
  • van der Wekken AJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Hendriks LEL; Department of Pulmonary Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Croes S; Department of Pulmonary Diseases, GROW-School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • van Geel RMJM; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Jansman FGA; CARIM School for Cardiovascular Disease, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Boshuizen RC; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Franssen EJF; CARIM School for Cardiovascular Disease, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Smit AAJ; Department of Clinical Pharmacy, Deventer Hospital, Deventer, The Netherlands.
  • Dumoulin DW; Unit of PharmacoTherapy, Epidemiology and Economics, Groningen Research Institute of Pharmacy (GRIP), University of Groningen, Groningen, The Netherlands.
  • Oude Munnink TH; Department of Pulmonology, Deventer Hospital, Deventer, The Netherlands.
  • Smit EF; Department of Clinical Pharmacy, Onze Lieve Vrouwe Gasthuis Hospital AC, Amsterdam, The Netherlands.
  • Derijks HJ; Department of Pulmonology, Onze Lieve Vrouwe Gasthuis Hospital AC, Amsterdam, The Netherlands.
  • van der Leest CH; Department of Pulmonary Medicine, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
  • Hendrikx JJMA; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Moes DJAR; Department of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands.
  • de Rouw N; Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Health Sciences, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, The Netherlands.
Target Oncol ; 18(3): 441-450, 2023 05.
Article em En | MEDLINE | ID: mdl-37081309

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Imunoconjugados / Neoplasias Pulmonares / Antineoplásicos Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Target Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda